FDA Inspection 1238080 — Bonavuth Pek, M.D.
The FDA completed an inspection of Bonavuth Pek, M.D. on Apr 19, 2024 in Saint-Charles-Borromee. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 19, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Saint-Charles-Borromee (Canada)
Additional Details
Clinical Investigator (CI)